Person

Michael F. Mahoney

Chairman, President & CEO · Director, Boston Scientific

Current S&P 500 boards
2
Current roles
2
Open-market buys
$11.5M
Open-market sales
$222.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 3, 2026BSXBuy186,240$48.33$9.0M
Feb 2, 2026BSXSale159,701$93.49$14.9M
Feb 2, 2026BSXSale1,200$94.06$113K
Jun 2, 2025BSXSale89,921$103.39$9.3M
Jun 2, 2025BSXSale74,522$104.05$7.8M
May 1, 2025BSXSale91,282$102.13$9.3M
May 1, 2025BSXSale73,161$102.92$7.5M
Apr 1, 2025BSXSale164,442$100.01$16.4M
Feb 18, 2025CVSBuy30,000$66.70$2.0M
Nov 5, 2024BSXSale160,182$84.74$13.6M
Nov 5, 2024BSXSale2,596$85.17$221K
Oct 7, 2024BSXSale80,692$84.31$6.8M
Oct 7, 2024BSXSale82,085$84.94$7.0M
Sep 5, 2024BSXSale162,777$81.17$13.2M
May 2, 2024CVSBuy9,181$54.49$500K
Nov 6, 2023BSXSale113,356$52.51$6.0M
Oct 9, 2023BSXSale113,355$52.09$5.9M
Sep 12, 2023BSXSale113,355$53.91$6.1M
Nov 7, 2022BSXSale125,827$41.97$5.3M
Oct 3, 2022BSXSale125,827$39.34$5.0M
Sep 6, 2022BSXSale125,828$40.49$5.1M
Aug 8, 2022BSXSale125,828$40.97$5.2M
Nov 1, 2021BSXSale201,042$43.05$8.7M
Oct 4, 2021BSXSale97,838$42.43$4.2M
Oct 4, 2021BSXSale103,204$43.39$4.5M
Sep 7, 2021BSXSale201,041$44.57$9.0M
Aug 2, 2021BSXSale201,043$45.74$9.2M
Jul 6, 2021BSXSale201,041$43.41$8.7M
Nov 3, 2020BSXSale259,207$35.06$9.1M
Nov 1, 2018BSXSale116,666$36.35$4.2M
Oct 1, 2018BSXSale116,666$38.80$4.5M
Sep 10, 2018BSXSale116,666$35.88$4.2M
Aug 1, 2016BSXSale44,400$24.44$1.1M
Jul 1, 2016BSXSale100,000$23.43$2.3M
Jun 1, 2016BSXSale100,000$22.69$2.3M
May 2, 2016BSXSale100,000$22.12$2.2M
Apr 1, 2016BSXSale100,000$18.90$1.9M
Mar 1, 2016BSXSale100,000$16.96$1.7M

SEC reporting-owner ID (CIK) 1533022 · all filings on EDGAR